Prognostic value of CD44 expression in penile squamous cell carcinoma: a pilot study

[1]  S. Savage,et al.  Contemporary diagnosis and management of squamous cell carcinoma (SCC) of the penis , 2011, BJU international.

[2]  R. Montironi,et al.  D2-40 immunoreactivity in penile squamous cell carcinoma: a marker of aggressiveness. , 2011, Human pathology.

[3]  H. Nagatsuka,et al.  Dickkopf (Dkk)-3 and β-catenin expressions increased in the transition from normal oral mucosal to oral squamous cell carcinoma , 2011, Journal of Molecular Histology.

[4]  N. Yazdani,et al.  Correlation between E-cadherin and CD44 adhesion molecules expression and cervical lymph node metastasis in oral tongue SCC: Predictive significance or not. , 2011, Pathology, research and practice.

[5]  E. Li,et al.  Cytoplasmic HDPR1 Is Involved in Regional Lymph Node Metastasis and Tumor Development via Beta-Catenin Accumulation in Esophageal Squamous Cell Carcinoma , 2011, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[6]  Li-Yan Xu,et al.  Tumor Initiating Cells in Esophageal Squamous Cell Carcinomas Express High Levels of CD44 , 2011, PloS one.

[7]  K. Alanen,et al.  Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma. , 2011, Oral oncology.

[8]  M. Zöller.  CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? , 2011, Nature Reviews Cancer.

[9]  M. Sakagami,et al.  CD44 expression is related to poor prognosis of hypopharyngeal squamous cell carcinoma , 2011, Acta oto-laryngologica.

[10]  J. Zanetti,et al.  Cancer stem cell immunophenotypes in oral squamous cell carcinoma. , 2011, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[11]  P. Thall,et al.  Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  X. Yao,et al.  Development and evaluation of a nomogram to predict inguinal lymph node metastasis in patients with penile cancer and clinically negative lymph nodes. , 2010, The Journal of urology.

[13]  F. Algaba,et al.  Developments in the pathology of penile squamous cell carcinomas. , 2010, Urology.

[14]  Kuan-Der Lee,et al.  Prognostic value of pretreatment CD44 mRNA in peripheral blood of patients with locally advanced head and neck cancer. , 2010, Oral oncology.

[15]  H. Saya,et al.  PSF1, a DNA replication factor expressed widely in stem and progenitor cells, drives tumorigenic and metastatic properties. , 2010, Cancer research.

[16]  N. Kekre,et al.  Factors predicting inguinal node metastasis in squamous cell cancer of penis , 2010, World Journal of Urology.

[17]  K. Kumamoto,et al.  CD44v6, MMP-7 and nuclear Cdx2 are significant biomarkers for prediction of lymph node metastasis in primary gastric cancer. , 2009, Oncology reports.

[18]  T. Wang,et al.  Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44 , 2009, Stem cells.

[19]  Jing Wang,et al.  Isolation and identification of cancer stem-like cells in esophageal carcinoma cell lines. , 2009, Stem cells and development.

[20]  H. Ahmed,et al.  Molecular prognostic factors in penile cancer , 2009, World Journal of Urology.

[21]  X. Wang,et al.  EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. , 2009, Gastroenterology.

[22]  A. Rubinstein,et al.  DNA vaccination with CD44 variant isoform reduces mammary tumor local growth and lung metastasis , 2008, Molecular Cancer Therapeutics.

[23]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[24]  G. Pirozzi,et al.  The stem cell hypothesis in head and neck cancer , 2008, Journal of cellular biochemistry.

[25]  I. Mackenzie,et al.  Stem cell patterns in cell lines derived from head and neck squamous cell carcinoma. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[26]  J. Rich,et al.  Chemotherapy and cancer stem cells. , 2007, Cell stem cell.

[27]  F. Esteban,et al.  Prognostic significance of p21WAF1/CIP1, p16INK4a and CD44s in tongue cancer. , 2007, Oncology reports.

[28]  Michael F. Clarke,et al.  Phenotypic characterization of human colorectal cancer stem cells , 2007, Proceedings of the National Academy of Sciences.

[29]  R. Beroukhim,et al.  Molecular definition of breast tumor heterogeneity. , 2007, Cancer cell.

[30]  H. Saya,et al.  ADAM-17 associated with CD44 cleavage and metastasis in oral squamous cell carcinoma , 2007, Virchows Archiv.

[31]  I. Weissman,et al.  Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma , 2007, Proceedings of the National Academy of Sciences.

[32]  M. Kattan,et al.  Nomogram predictive of cancer specific survival in patients undergoing partial or total amputation for squamous cell carcinoma of the penis. , 2006, The Journal of urology.

[33]  M. Kattan,et al.  Nomogram predictive of pathological inguinal lymph node involvement in patients with squamous cell carcinoma of the penis. , 2006, The Journal of urology.

[34]  N. Maitland,et al.  Prospective identification of tumorigenic prostate cancer stem cells. , 2005, Cancer research.

[35]  Jun Li,et al.  Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer. , 2005, World journal of gastroenterology.

[36]  Y. Hao,et al.  DEPLETION OF HEAT SHOCK PROTEIN-70 (HSP70) CAUSES APOPTOSIS IN PANCREATIC CANCER CELLS , 2005 .

[37]  C. Isacke,et al.  The role of the CD44 transmembrane and cytoplasmic domains in co-ordinating adhesive and signalling events , 2003, Journal of Cell Science.

[38]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[39]  E. Solsona,et al.  Prospective validation of the association of local tumor stage and grade as a predictive factor for occult lymph node micrometastasis in patients with penile carcinoma and clinically negative inguinal lymph nodes. , 2001, Journal of Urology.

[40]  P. Tamboli,et al.  Tumor stage, vascular invasion and the percentage of poorly differentiated cancer: independent prognosticators for inguinal lymph node metastasis in penile squamous cancer. , 2001, The Journal of urology.

[41]  M. Fujita,et al.  Reduced expression of CD44 variant 9 is related to lymph node metastasis and poor survival in squamous cell carcinoma of tongue. , 2000, Oral oncology.

[42]  M. Ducreux,et al.  A phase II study: docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma. , 2000, European journal of cancer.

[43]  A. Berghold,et al.  CD44 expression in sinonasal melanomas: is loss of isoform expression associated with advanced tumour stage? , 1999, The Journal of pathology.

[44]  D. Mangham,et al.  The normal structure and function of CD44 and its role in neoplasia. , 1998, Molecular pathology : MP.

[45]  Viviane,et al.  Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation. , 1996, The American journal of pathology.

[46]  H. Niitani,et al.  [Phase II study]. , 1995, Gan to kagaku ryoho. Cancer & chemotherapy.

[47]  J. Narula,et al.  Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. , 1994, Cancer research.

[48]  P. Herrlich,et al.  A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells. , 1993, Cancer research.

[49]  I. Stamenkovic,et al.  CD44H regulates tumor cell migration on hyaluronate-coated substrate , 1992, The Journal of cell biology.

[50]  Martin Hofmann,et al.  A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells , 1991, Cell.

[51]  Brian Seed,et al.  A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family , 1989, Cell.

[52]  J. Fabre,et al.  Monoclonal antibody to a human leukocyte‐specific membrane glycoprotein probably homologous to the leukocyte‐common (L‐C) antigen of the rat , 1980, European journal of immunology.

[53]  A. C. Broders.  SQUAMOUS‐CELL EPITHELIOMA OF THE SKIN A STUDY OF 256 CASES , 1921, Annals of surgery.

[54]  John W. Davis,et al.  Tumors of the Penis , 2012 .

[55]  C. Tseng,et al.  Evaluation of the prognostic value of CD44 in glioblastoma multiforme. , 2010, Anticancer research.

[56]  V. Kosma,et al.  CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma. , 2007, Oral oncology.

[57]  J. Nesland,et al.  Expression of CD44 Isoforms in Infiltrating Lobular Carcinoma of the Breast , 2004, Breast Cancer Research and Treatment.

[58]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.